NCT03109873View on ClinicalTrials.gov

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 5, 2017

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
LarynxLipOral CavityPharynx
Interventions
RADIATION

External Beam Radiation Therapy

Undergo External Beam Radiation Therapy

DRUG

Metformin Hydrochloride

Given orally

OTHER

Placebo

Given orally

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03109873 - Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter